Treace Medical Concepts I...

NASDAQ: TMCI · Real-Time Price · USD
6.89
-0.06 (-0.86%)
At close: Aug 15, 2025, 3:59 PM
6.89
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

Treace Medical Concepts Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-49.18M -52.99M -55.74M -61.52M -63.68M -54.75M -49.53M -47.66M -42.27M -47.23M -42.81M -45.02M -39.31M -27.16M -20.55M -11.37M -7.6M -4.49M
Depreciation & Amortization
9.32M 8.97M 8.42M 7.95M 7.36M 6.34M 5.35M 4.5M 3.4M 2.72M 2.13M 1.49M 1.22M 902K 685K 617K 763K 1.02M
Stock-Based Compensation
34.73M 31.89M 30.6M 27.92M 25.21M 22.07M 17.35M 13.95M 11.03M 9.39M 8.11M 6.93M 5.5M 4.42M 3.41M 2.45M 1.74M 1.11M
Other Working Capital
-8.59M -5.06M -8.42M -3.69M 2.98M 2.13M 6.21M 4.79M 5.43M 6.16M 9.39M 8.75M 7.97M 4.09M 4.19M 614K 576K 3.4M
Other Non-Cash Items
4.06M 5.67M 4.99M 22.77M 24.15M 22.46M 22.32M 3.48M 3.59M 3.73M 3.6M 2.18M 1.28M 451K 176K 186K 191K 199K
Deferred Income Tax
n/a n/a n/a -19.61M -19.98M -20.3M -20.3M -693K -326K n/a n/a 368K 403K 523K 419K 815K 1.52M 1.91M
Change in Working Capital
-13.82M -19.29M -25.43M -9.94M -3.16M -347K -9.77M -14.05M -13.85M -13.4M -5.81M 876K -4.06M -3.12M -1.33M -3.7M -2.54M -3.8M
Operating Cash Flow
-14.9M -25.75M -37.17M -32.43M -30.1M -24.54M -34.58M -40.47M -38.44M -40.67M -30.65M -29.04M -30.82M -23.99M -17.19M -10.99M -5.93M -4.04M
Capital Expenditures
-14.25M -11.21M -11.59M -10.77M -11.4M -13.91M -11.46M -11.54M -13.9M -14.84M -14.84M -13.41M -8.49M -3.99M -2.71M -1.89M -1.01M -591K
Cash Acquisitions
n/a n/a n/a -7.25M -15.35M -35.35M -34.64M 34.29M 42.39M 62.39M 61.68M n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-73.12M -57.96M -71.58M -82.68M -77.62M -99.03M -169.87M -203.48M -184.37M -162.96M -63.41M n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
91.4M 98.89M 118.55M 130.41M 124.82M 135.87M 120.02M 84.71M 57.49M 22.28M 1.73M n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 7.25M 15.35M 29.16M 28.45M -40.48M -48.58M -62.39M -61.68M n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
4.03M 29.72M 35.38M 36.96M 35.8M 2.94M -81.3M -150.32M -160.77M -155.52M -76.52M -13.41M -8.49M -3.99M -2.71M -1.89M -1.01M -591K
Debt Repayment
885K n/a n/a n/a n/a n/a n/a n/a n/a 19.61M 19.61M 19.61M 19.61M n/a n/a n/a n/a 1.79M
Common Stock Repurchased
n/a n/a n/a n/a n/a -6.32M -6.32M -6.32M -6.32M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -7.93M -7.93M -7.93M -7.93M n/a n/a n/a
Other Financial Acitivies
-381K -367K -203K -250K -250K 930K 1.52M 1.83M 2.18M 178K 1.2M 1.93M 1.61M 110.24M 107.08M 106.38M 115.69M 7.89M
Financial Cash Flow
739K 63K 160K 299K 450K 1.32M 109.38M 109.52M 109.71M 127.31M 20.81M 21.54M 21.22M 110.24M 107.65M 106.95M 116.26M 10.25M
Net Cash Flow
-10.13M 4.04M -1.63M 4.83M 6.15M -20.28M -6.49M -81.27M -89.5M -68.87M -86.36M -20.91M -18.09M 82.27M 87.75M 94.06M 109.32M 5.62M
Free Cash Flow
-29.15M -36.96M -48.76M -43.2M -41.5M -38.44M -46.03M -52.01M -52.33M -55.5M -45.49M -42.45M -39.31M -27.98M -19.9M -12.89M -6.94M -4.64M